Advertisement

Document › Details
Sartorius AG. (9/27/21). "Press Release: Sartorius to Expand Business Operations in North America". Ann Arbor, MI.
![]() |
Region | Ann Arbor, MI |
Country | United States (USA) | |
![]() |
Organisation | Sartorius Center of Excellence for Bioanalytics, Ann Arbor, MI |
Group | Sartorius (Group) | |
Organisation 2 | The Tech Loop at Ann Arbor Research Park | |
![]() |
Product | RNA-targeting small molecule drugs (rSMs) |
Product 2 | venture capital | |
![]() |
Person | Lavin, Mary (Sartorius 202109 President of Sartorius North America) |
Person 2 | Kirchhoff, Petra (Sartorius 201401 VP Group Corporate Communications + IR) | |
> 130,000-square-foot plant in Ann Arbor, Michigan
> 160 new jobs to be created from initiative
> Opening of facility by year end 2023
Sartorius, a leading international partner of life science research and the biopharmaceutical industry, is expanding its presence in Michigan. Sartorius will open a new 130,000-square-foot (12,000-square-meter) state-of-the art plant in Ann Arbor in late 2023.
“The new facility will consolidate existing business operations in Washtenaw County to create a center of excellence in Ann Arbor for the Laboratory and Bioprocess Products and Services in North America, which focus on providing innovative solutions to help customers develop drugs that cure, prevent, and halt the progression of diseases,” said Mary Lavin, President of Sartorius North America.
Sartorius will have an anchoring presence in the Tech Loop at the Ann Arbor Research Park and add a flagship site in North America. To this end, the company has purchased over 15 acres of land which provides sufficient space for further expansion. The project is expected to create 160 jobs over three years. These jobs will include product development, operations, and other support functions.
Demand for innovative technologies used in the development and production of biopharmaceuticals continues to grow rapidly. The Ann Arbor site is an integral part of Sartorius’ ongoing worldwide expansion, enabling Sartorius to scale up its operations and capabilities in the Ann Arbor biotech hub. By 2025,Sartorius will more than double capacities for its key product groups.
This press release contains forward-looking statements about the future development of the Sartorius Group. Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from those expressed or implied by such statements. Sartorius assumes no liability for updating such statements in light of new information or future events.
A profile of Sartorius
The Sartorius Group is a leading international partner of life science research and the biopharmaceutical industry. With innovative laboratory instruments and consumables, the Group’s Lab Products & Services Division concentrates on serving the needs of laboratories performing research and quality control at pharma and biopharma companies and those of academic research institutes. The Bioprocess Solutions Division with its broad product portfolio focusing on single-use solutions helps customers to manufacture biotech medications and vaccines safely and efficiently. The Group has been annually growing by double digits on average and has been regularly expanding its portfolio by acquisitions of complementary technologies. In fiscal 2020, the company earned sales revenue of some 2.34 billion euros. At the end of 2020, nearly 11,000 people were employed at the Group’s approximately 60 manufacturing and sales sites, serving customers around the globe.
Follow Sartorius on Twitter and on LinkedIn.
Contact
Petra Kirchhoff
Head of Corporate Communications & Investor Relations
+49 (0)551 308 1686
[email protected]
Record changed: 2023-06-05 |
Advertisement

More documents for Sartorius (Group)
- [1] Sartorius AG. (12/6/24). "Press Release: Michael Grosse to Succeed Joachim Kreuzburg as Chief Executive Officer of Sartorius AG". Göttingen....
- [2] Sartorius AG. (7/2/24). "Press Release: Sartorius AG – After more than 20 Years as CEO, Joachim Kreuzburg Will Not Pursue another Term in Office – Supervisory Board Expresses Great Regret". Göttingen....
- [3] Sartorius AG. (6/5/24). "Press Release: Sartorius Opens New Center of Excellence for Bioanalytics in Ann Arbor". Ann Arbor, MI....
- [4] Refeyn Ltd.. (5/22/24). "Press Release: Refeyn Announces Appointment of Fiona Coats as Chief Marketing Officer". Oxford....
- [5] Sartorius AG. (5/16/24). "Press Release: Sartorius to Advance Drug Discovery and Manufacturing with AI in Collaboration with Nvidia". Göttingen....
- [6] Sartorius AG. (5/13/24). "Press Release: Sartorius Collaborates with Sanofi to Commercialize End-to-end Platform for Downstream process intensification". Göttingen....
- [7] Sartorius AG. (4/9/24). "Press Release: Sartorius and TheWell Bioscience Partner to Enable more Accurate Predictions in Drug Discovery". Göttingen....
- [8] Sartorius AG. (8/17/23). "Press Release: Sartorius and Repligen Corporation Launch Integrated System with Biostat STR and XCell ATF for Upstream Process Intensification". Göttingen....
- [9] Sartorius AG. (8/3/23). "Press Release: Florian Funck Appointed CFO of Sartorius. New CFO to Take Over as of April 2024". Göttingen....
- [10] Waters Corporation. (6/5/23). "Press Release: Waters and Sartorius Expand Collaboration to Deliver Comprehensive Bioanalytics for Downstream Biomanufacturing". Milford, MA & Göttingen....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top